S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › KP2 › Research report
← KP2 page
XStocksXray
Market X-Ray report · 19 October 2026

Kore Potash Plc (KP2)

London Exchange · UK · prices in GBX · close of 19 Oct 2026

Key indicators

Last closeGBX 3.660
52-week range2.705 – 3.900
Return, 1 month / 3 months+1.7% / +10.9%
Return, 1 year / 3 years+16.2% / +565.5%
TrendUptrend
RSI (14)49
Volatility (1 year)45.6%
Worst drawdown (1 year)-26.3%
Average daily value traded16.49M GBX
Dividend yield–

Market X-Ray price-based

68/ 100 · High confidence · ahead of 81% of stocks on this exchange
Trend79
Momentum73
Stability (higher is calmer)45
Liquidity77
Income–

Five-year price chart navy: price · brown: 200-day average

0.141.242.343.444.542021-102023-012024-042025-072026-10

About the company

Kore Potash is a mineral development company focused on potash, a key ingredient in fertilisers used by agricultural growers. Its projects are located in the Republic of Congo, where it works on the Sintoukola potash deposits, including the Kola and Dougou areas. The company is based in the United Kingdom and is working towards developing these potash resources for the global fertiliser market.

On this site Kore Potash Plc appears as a stock on the London Exchange (UK), code KP2, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Kore Potash Plc (KP2) trades on the London Exchange in UK. It last closed at GBX 3.660 on 19 October 2026.

Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 713 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 16.2% and over the last three months it rose 10.9%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Kore Potash Plc (KP2)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend79 · StrongTrading above its long-term averages and near its highs.
Above 200-day average12.2%
From 52-week high-3.7%
Momentum73 · StrongRising faster than most stocks on this exchange.
3-month return10.9%
6-month return16.2%
12-month return, skipping the last month14.3%
Stability (higher is calmer)45 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)45.6%
Worst drawdown, 1 year (smaller is calmer)-26.3%
Liquidity77 · StrongTrades actively.
Average daily value traded16.49M GBX
Zero-volume days1.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.
  • Liquidity: Trades actively.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−2.7%
1 month+1.7%
3 months+10.9%
6 months+16.2%
1 year+16.2%
3 years+565.5%
5 years+218.3%

Signals

50-day / 200-day average3.516 / 3.261
Golden / death cross (60 days)Golden, 38 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.189

Technical summary

DailyNeutral7 bullish · 4 neutral · 5 bearish
WeeklyStrongly bullish11 bullish · 1 neutral · 0 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026